Business · 1 sources covering this

Skyways Air vs Symbiotec vs Hy-Tech: Analysts pick their top IPO bet

Symbiotec Pharmalab stands out as the preferred long-term pick, backed by SBI Securities' 'Subscribe' rating and Master Capital's positive view on its specialised business.

Share:WhatsApp X Reddit Facebook LinkedIn

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

Business StandardCenter·1h ago
Skyways Air vs Symbiotec vs Hy-Tech: Analysts pick their top IPO bet
Symbiotec Pharmalab stands out as the preferred long-term pick, backed by SBI Securities' 'Subscribe' rating and Master Capital's positive view on its specialised business.
Read at Business Standard →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/c4cf324f3d3eacb3da78164d6bdfa3aadc797901"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Skyways Air vs Symbiotec vs Hy-Tech: Analysts pick their top IPO bet"></iframe>

Skyways Air vs Symbiotec vs Hy-Tech: Analysts pick their top IPO bet

How 1 sources are covering this

Skyways Air vs Symbiotec vs Hy-Tech: Analysts pick their top IPO bet

More from Business

Hayden Panettiere’s mother breaks silence after actress’ death at 36: ‘I still am not grasping this is real’

Oil price today: Brent crude stays above $90 as Middle East standoff intensifies

Gold loan market gets crowded: Will new entrants dull incumbents' sheen?

US Eyes China Overcapacity Tariffs Of 7.5% Before Xi Visits

Reader

Trust & legal

Across the network